Exclusive

Publication

Byline

Clinical Trial: Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07506161) titled 'Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas' on March 13. B... Read More


Clinical Trial: Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07505173) titled 'Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metasta... Read More


Clinical Trial: Comparison of Intertransverse Process and Erector Spinae Plane Blocks in Acute Postoperative Analgesia Management for Laparoscopic Cholecystectomy Patients

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07504705) titled 'Comparison of Intertransverse Process and Erector Spinae Plane Blocks in Acute Postoperativ... Read More


Clinical Trial: Acupressure for Pain, Injection Fear, and Satisfaction in Intramuscular Injection Patients

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07505992) titled 'Acupressure for Pain, Injection Fear, and Satisfaction in Intramuscular Injection Patients'... Read More


Clinical Trial: A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07506109) titled 'A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Pa... Read More


Clinical Trial: Using BlazePod(R) for Pre-Season Screening of Lower Limb Injury Risk

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07505537) titled 'Using BlazePod(R) for Pre-Season Screening of Lower Limb Injury Risk' on March 26. Brief S... Read More


Clinical Trial: Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07505186) titled 'Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamou... Read More


Clinical Trial: Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07505472) titled 'Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy... Read More


Clinical Trial: Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07505667) titled 'Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss' on March 21. Brief Summ... Read More


Clinical Trial: Comparative Effectiveness of Clindamycin-Retinoid, Clindamycin-Retinoid-Dexamethasone, and 10% SM-hUCMSC Secretome Gel in the Improvement of Mild-to-Moderate Acne Vulgaris

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07504822) titled 'Comparative Effectiveness of Clindamycin-Retinoid, Clindamycin-Retinoid-Dexamethasone, and ... Read More